Global Drugs in Development Plan Database 2019: Candidates in Phase I-III Trials, Expired, Pending, and Abandoned Patents, Active US & International Patents, Clinical Trial Progress & API Vendors - ResearchAndMarkets.com
The "Drugs in Development Plan Database" newsletter has been added to ResearchAndMarkets.com's offering.
The Drugs in Development Plan Database helps drug companies make better decisions through the delivery of cutting-edge business intelligence. The Drugs-in-Development plan is focused on the interests of pharmaceutical and biotechnology drug manufacturers, suppliers, distributors, and payers.
Key Topics Covered:
- Drug Candidates in Phase I-III Clinical Trials
- Expired, Pending, and Abandoned Patents
- Active US & International Patents
- Clinical Trial Progress
- API Vendors
For more information about this newsletter visit https://www.researchandmarkets.com/research/qjvgw7/global_drugs_in?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20190204005364/en/